Trimethoprim-Sulfamethoxazole (Bactrim) Dose Optimization in Pneumocystis jirovecii Pneumonia (PCP) Management: A Systematic Review

(1) Background: Pneumocystis jirovecii pneumonia (PCP) has a substantial impact on the morbidity and mortality of patients, especially those with autoimmune disorders, thus requiring optimal dosing strategies of Trimethoprim–Sulfamethoxazole (TMP-SMX). Therefore, to ensure the safety of TMP-SMX, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Haseeb, Abdul, Abourehab, Mohammed A. S., Almalki, Wesam Abdulghani, Almontashri, Abdulrahman Mohammed, Bajawi, Sultan Ahmed, Aljoaid, Anas Mohammed, Alsahabi, Bahni Mohammed, Algethamy, Manal, AlQarni, Abdullmoin, Iqbal, Muhammad Shahid, Mutlaq, Alaa, Alghamdi, Saleh, Elrggal, Mahmoud E., Saleem, Zikria, Radwan, Rozan Mohammad, Mahrous, Ahmad Jamal, Faidah, Hani Saleh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910260/
https://www.ncbi.nlm.nih.gov/pubmed/35270525
http://dx.doi.org/10.3390/ijerph19052833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910260/
https://www.ncbi.nlm.nih.gov/pubmed/35270525
http://dx.doi.org/10.3390/ijerph19052833

Ejemplares similares